ArticleCell insight2026
Febrile-range temperature selectively limits sustained pDC-Derived IFN-α via attenuation of STAT1-Dependent feedback signaling.
Article in Cell insight, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Plasmacytoid dendritic cells (pDCs) are specialized sentinels of antiviral immunity and the dominant early source of interferon-α (IFN-α) during viral infection. While pDC-derived IFN-α restricts viral replication and provides a critical third signal for T cell activation, sustained type I interferon (IFN-I) signaling can drive immunopathology, and the physiological mechanisms that constrain this response remain incompletely understood. Here, we identify fever as a conserved host factor that selectively limits IFN-α production by pDCs. We show that febrile-range temperature does not impair early IFN-α induction but instead suppresses sustained IFN-α output in human and mouse pDCs. Mechanistically, elevated temperature attenuates signal transducer and activator of transcription 1 (STAT1) phosphorylation, thereby disrupting the IFN-I-dependent positive feedback loop required for IFN-I amplification following CpG-A stimulation. Pharmacological inhibition of protein phosphatase activity with okadaic acid (OA) restores STAT1 phosphorylation and rescues IFN-α production under febrile conditions. Together, these findings establish fever as a physiological regulator of pDC-derived IFN-I responses and reveal a temperature-dependent mechanism that constrains prolonged IFN-I production to prevent excessive immune activation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.